Person

Jeffrey Bluestone

Director, Gilead Sciences

Current S&P 500 boards
1
Current roles
1
Open-market buys
$0
Open-market sales
$3.1M

Current roles

From Section 16 filings (Forms 3, 4 and 5) in the last 13 months.

Past roles

“Last filing” is the latest Form 3/4/5 for that company, an upper bound on the end date.

None on record since 2016.

Sits alongside

People who currently share a board or management team with this person.

Open-market trades

Purchases and sales reported on Form 4 at S&P 500 companies.

DateCompanyTypeSharesPriceValue
Aug 20, 2026GILDSale1,658$145.73$242K
Aug 20, 2026GILDSale1,816$144.92$263K
Aug 20, 2026GILDSale1,165$143.75$167K
Aug 20, 2026GILDSale335$146.26$49K
Aug 20, 2026GILDSale26$146.36$4K
Jan 20, 2026GILDSale5,000$123.50$618K
Nov 28, 2025GILDSale5,000$125.08$625K
Jul 14, 2025GILDSale5,000$109.74$549K
Nov 26, 2024GILDSale6,788$91.39$620K

SEC reporting-owner ID (CIK) 1771814 · all filings on EDGAR

Jeffrey Bluestone (GILD) | USBoard